Home
Conditions
Solid Tumors

Clinical trial condition

Solid Tumors

Explore clinical trials studying Solid Tumors. Study availability and eligibility vary by location and protocol.

582 public trials 81 recruiting studies

Refine in advanced search Browse all conditions

Solid Tumors trial results

Completed

A Dose Escalation Study of OMP-54F28 in Subjects With Solid Tumors

NCT01608867

Conditions: Neoplasm Metastasis, Neoplasms, Neoplastic Processes, +3 more
Locations: Pinnacle Oncology Hematology, Scottsdale, Arizona, United States

University of Colorado Hospital Aurora, Colorado, United States

University of Michigan Health System Ann Arbor, Michigan, United States

View Trial Details

Completed

A Japanese Phase 1 Trial of c-Met Inhibitor MSC2156119J in Subjects With Solid Tumors

NCT01832506

Conditions: Solid Tumors
Locations: Research site Kashiwa, Japan

Research site Shizuoka, Japan

View Trial Details

Completed

A Study of RC48-ADC in Subjects With HER2-Positive Advanced Malignant Solid Tumors

NCT02881138

Conditions: Solid Tumors
Locations: Cancer Hospital Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China

View Trial Details

Completed

Safety Study of PLX3397 and Paclitaxel in Patients With Advanced Solid Tumors

NCT01525602

Conditions: Solid Tumors
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Univeristy of California, San Francisco San Francisco, California, United States

University of Colorado, Anschutz Cancer Pavilion Aurora, Colorado, United States

Sylvester Comprehensive Cancer Center/UMHC Miami, Florida, United States

View Trial Details

Completed

Registry Study for Personalized Cancer Therapy

NCT02508662

Conditions: Advanced Cancers, Solid Tumors
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Dose Escalation, Multi-arm Study of MLN4924 Plus Docetaxel, Gemcitabine, or Combination of Carboplatin and Paclitaxel in Participants With Solid Tumors

NCT01862328

Conditions: Solid Tumors
Locations: Atlanta, Georgia, United States

St Louis, Missouri, United States

Chapel Hill, North Carolina, United States

Cleveland, Ohio, United States

View Trial Details

Completed

Study of RC48-ADC Administered Intravenously to Subjects With HER2-Positive in Advanced Malignant Solid Tumors

NCT02881190

Conditions: Solid Tumors
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

View Trial Details

Completed

A Safety and Tolerability Study of Pemigatinib in Japanese Subjects With Advanced Malignancies - (FIGHT-102)

NCT03235570

Conditions: Acrocephalosyndactylia, Bone Diseases, Bone Diseases, Developmental, +12 more
Locations: Aichi Cancer Center Hospital Aichi, Japan

Chiba Cancer Center Chiba, Japan

National Cancer Central Hospital East Chiba, Japan

Kyusyu Cancer Center Fukuoka, Japan

View Trial Details

Completed

A Study of RO6958688 in Participants With Locally Advanced and/or Metastatic Carcinoembryonic Antigen Positive Solid Tumors

NCT02324257

Conditions: Solid Tumors
Locations: Cedars Sinai Medical Center; Samuel-Oschin Comprehensive Cancer Institute Los Angeles, California, United States

Stanford University Palo Alto, California, United States

UCLA Cancer Center Santa Monica, California, United States

University Of Colorado Aurora, Colorado, United States

View all 21 locations

View Trial Details

Completed

A Study in Healthy Subjects to Assess the Pharmacokinetics of Savolitinib When Administered Alone and in Combination With Rifampicin

NCT04118842

Conditions: Solid Tumors
Locations: Research Site Baltimore, Maryland, United States

View Trial Details

Solid Tumors

Solid Tumors trial results

Related conditions